These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 14626984

  • 21. The Food and Drug Administration's evolving regulation of press releases: limits and challenges.
    Vodra WW, Cortez NG, Korn DE.
    Food Drug Law J; 2006; 61(4):623-51. PubMed ID: 17180767
    [No Abstract] [Full Text] [Related]

  • 22. Public Health and the First Amendment.
    Sharfstein JM.
    Milbank Q; 2015 Sep; 93(3):459-62. PubMed ID: 26350923
    [No Abstract] [Full Text] [Related]

  • 23. FDA regulation of Internet pharmaceutical communications: strategies for improvement.
    Loza EL.
    Food Drug Law J; 2000 Sep; 55(2):269-92. PubMed ID: 12269369
    [No Abstract] [Full Text] [Related]

  • 24. Direct-to-consumer advertising of prescription drugs.
    Frosch DL, Grande D.
    LDI Issue Brief; 2010 Sep; 15(3):1-4. PubMed ID: 20469541
    [Abstract] [Full Text] [Related]

  • 25. The new drug marketing: a consumer protection perspective.
    Woodward D.
    Food Drug Law J; 1996 Sep; 51(4):637-50. PubMed ID: 11797733
    [No Abstract] [Full Text] [Related]

  • 26. Direct-to-consumer advertising of prescription medications: Do you see what the public sees?
    Hampl JS, Bramlett-Solomon S, Wharton CM.
    J Am Diet Assoc; 2006 Dec; 106(12):1937-40, 1942-3, 1945-6. PubMed ID: 17126621
    [No Abstract] [Full Text] [Related]

  • 27. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
    Berndt ER.
    N Engl J Med; 2005 Jan 27; 352(4):325-8. PubMed ID: 15673797
    [No Abstract] [Full Text] [Related]

  • 28. Pharmaceuticals and medical devices: FDA oversight.
    Health Policy Tracking Service, a service of Thomson Reuters Accelus, Berry MD.
    Issue Brief Health Policy Track Serv; 2012 Jan 03; ():1-86. PubMed ID: 22403845
    [No Abstract] [Full Text] [Related]

  • 29. Major issues in marketing regulation.
    Pines WL.
    Food Drug Law J; 1997 Jan 03; 52(3):297-302. PubMed ID: 10343028
    [No Abstract] [Full Text] [Related]

  • 30. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims.
    Schramm MJ.
    Food Drug Law J; 1996 Jan 03; 51(2):323-9. PubMed ID: 11822325
    [No Abstract] [Full Text] [Related]

  • 31. "It's time to make a good agency better": the Food and Drug Administration Modernization Act of 1997 and the First Amendment.
    Murphy AM.
    Food Drug Law J; 1998 Jan 03; 53(4):603-25. PubMed ID: 10557579
    [No Abstract] [Full Text] [Related]

  • 32. The development of direct-to-consumer prescription drug advertising regulation.
    Palumbo FB, Mullins CD.
    Food Drug Law J; 2002 Jan 03; 57(3):423-43. PubMed ID: 12703509
    [No Abstract] [Full Text] [Related]

  • 33. Off-label prescription advertising, the FDA and the First Amendment: a study in the values of commercial speech protection.
    Klasmeier C, Redish MH.
    Am J Law Med; 2011 Jan 03; 37(2-3):315-57. PubMed ID: 21847884
    [No Abstract] [Full Text] [Related]

  • 34. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Thomson Reuters/West.
    Issue Brief Health Policy Track Serv; 2011 Jan 03; ():1-39. PubMed ID: 21374841
    [No Abstract] [Full Text] [Related]

  • 35. The role of direct-to-consumer advertising.
    Navarro RP.
    Manag Care Interface; 1998 Nov 03; 11(11):79-80, 82. PubMed ID: 10187419
    [No Abstract] [Full Text] [Related]

  • 36. Examining the FDA's oversight of direct-to-consumer advertising.
    Gahart MT, Duhamel LM, Dievler A, Price R.
    Health Aff (Millwood); 2003 Nov 03; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243
    [Abstract] [Full Text] [Related]

  • 37. FDA drops legal battle to introduce graphic pictures on cigarette packs.
    Davies E.
    BMJ; 2013 Mar 22; 346():f1913. PubMed ID: 23526043
    [No Abstract] [Full Text] [Related]

  • 38. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Berry MD.
    Issue Brief Health Policy Track Serv; 2012 Dec 31; ():1-79. PubMed ID: 23297449
    [No Abstract] [Full Text] [Related]

  • 39. A bitter pill for plaintiffs: obstacles to market theories of causation in prescription drug consumer fraud cases.
    Arden JD, Brensilver PC.
    Food Drug Law J; 2006 Dec 31; 61(3):539-46. PubMed ID: 17001790
    [No Abstract] [Full Text] [Related]

  • 40. The FDA's graphic tobacco warnings and the first amendment.
    Orentlicher D.
    N Engl J Med; 2013 Jul 18; 369(3):204-6. PubMed ID: 23803137
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.